Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
A single plasmacytoma (SBP), monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are all NOT cancer. They are pre-myeloma. A oncologist might call them blood disorders. But they are not multiple myeloma.
There are a host of evidence-based but non-toxic therapies shown to reduce the risk of a MM diagnosis. Consider supplementation (curcumin, omega-3, green tea extract, others), anti-angiogenic nutrition, and lifestyle therapies.
I am both a myeloma survivor and myeloma cancer coach. Have you been diagnosed with pre-MM? Scroll down the page, post a question or comment and I will answer you ASAP.
“Although the break was fixed, a biopsy revealed that it was caused by a solitary plasmacytoma, a cluster of cancerous plasma cells found in a single site, usually bone..
Plasma cells are a type of white blood cell that produces antibodies. When they become abnormal, the cells are called myeloma, and when myeloma cells collect in several areas of the body, the resulting disease is called
But Herrin doesn’t have multiple myeloma – not yet.
Herrin had radiation to treat the plasmacytoma in his arm, and a PET scan revealed small lesions on his thoracic spine, sacrum and ribs. The scan indicated that the cancer may have spread, but wasn’t conclusive enough to warrant further treatment…
“Now we have to wonder how long the lesions will sit there. We can’t pretend they’re not there, but we don’t know what they mean. The best-case scenario is that everything just sits right where it is...
But you begin to wonder what you can do instead of just waiting.”
“Smoldering multiple myeloma (SMM) is a heterogeneous clinical entity that defines patients in the spectrum of disease progression from monoclonal gammopathy of undetermined significance to multiple myeloma (MM). Current standard of care is observation until end organ damage occurs. In spite of this, the scientific community has begun to question whether the strategy of watchful waiting should be replaced with earlier therapeutic intervention with the ultimate goal of preventing clonal heterogeneity and end organ damage…
“A recent pilot study found that curcumin, in certain patients with monoclonal gammopathy of undetermined significance (MGUS), decreases the paraprotein load…”